Fibromyalgia Treatment Market Size to Worth USD 4.13 Billion by 2032 [Yahoo! Finance]
NeuroMetrix, Inc. (NURO)
Last neurometrix, inc. earnings: 4/20 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.neurometrix.com/investor-relations
Company Research
Source: Yahoo! Finance
end of 2032, a study published by Towards Healthcare a sister firm of Precedence Research. Ottawa, June 05, 2024 (GLOBE NEWSWIRE) -- The global fibromyalgia treatment market size is estimated to grow from USD 2.77 billion in 2023 to approximately USD 4.13 billion by 2032. This growth is expected to be driven by a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032. Download a short version of Fibromyalgia Treatment Market report analysis in detail (TOC) @ Get Sample Report of Fibromyalgia Treatment Market Here Report Highlights: Development of innovative treatment options for Fibromyalgia. Growing demand for Fibromyalgia treatment augments the market growth. Medications reported the largest 68% market share in 2023. Retail pharmacies were the dominant distributors with a 54% market share in 2023. North America with 40% market share was the prominent market contributor in 2023. About 4 million adults in the United States, which is roughly 2% of the adult popu
Show less
Read more
Impact Snapshot
Event Time:
NURO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NURO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NURO alerts
High impacting NeuroMetrix, Inc. news events
Weekly update
A roundup of the hottest topics
NURO
News
- NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- NeuroMetrix Reiterates its Review of Strategic Alternatives [Yahoo! Finance]Yahoo! Finance
- NeuroMetrix Reiterates its Review of Strategic AlternativesGlobeNewswire
NURO
Sec Filings
- 8/6/24 - Form 10-Q
- 8/6/24 - Form 8-K
- NURO's page on the SEC website